Discover

GOSS
Gossamer Bio, Inc.
0.17
4 x 0.16
2 x 0.16
bid
ask
+
0.00
1.88%
3 @ 04:00 PM
0.17 +0.00 (2.50%)
Ytd-94.59%
1y-86.58%
0.16
day range
0.17
0.14
52 week range
3.87
Open0.17Prev Close0.16Low0.16High0.17Mkt Cap81.98M
Vol11.30MAvg Vol11.93MEPS-0.79P/EN/AForward P/E-1.24
Beta1.96Short Ratio6.29Inst. Own77.48%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0550-d Avg0.25200-d Avg1.661yr Est7.61

GOSS News

Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured First Lien Notes due 2030 and Exercise Price for Purchase Warrants
businesswire.com
Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured F

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (NASDAQ: GOSS) (the “Company” or “Gossamer”), a bioph

benzinga.com
HC Wainwright & Co. Maintains Buy on Gossamer Bio, Lowers Price Target to $2

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a B

benzinga.com
Gossamer Bio Completes Debt Exchange, Converting $181M Of 2027 Notes Into New Secured Notes And Equi

Gossamer Bio, Inc. (NASDAQ:GOSS) (the "Company" or "Gossamer"), a biopharmaceutical

benzinga.com
HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $5 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

Gossamer Bio Reports Q1 2026 Results: Full Earnings Call Transcript
benzinga.com
Gossamer Bio Reports Q1 2026 Results: Full Earnings Call Transcript

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga.com
Gossamer Bio Launches Exchange Offer For $72M New 7.5% Notes, Up To 317.6M Shares/Prefunded Warrants

Gossamer Bio, Inc. (NASDAQ:GOSS) (the "Company"), a biopharmaceutical company focused on the

benzinga.com
Gossamer Bio Q1 EPS $(0.20) Misses $(0.13) Estimate, Sales $16.955M Beat $4.475M Estimate

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.20) per share which missed the analyst c

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

This Box Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
benzinga.com
This Box Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed outlook on top names, downgrading ZBH, GOSS, TRI, PCG, and BOX. See

benzinga.com
Gossamer Bio Q4 EPS $(0.21) Misses $(0.18) Estimate, Sales $13.799M Beat $7.522M Estimate

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.21) per share which missed the analyst c

benzinga.com
HC Wainwright & Co. Maintains Buy on Gossamer Bio, Lowers Price Target to $5

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a B

benzinga.com
Oppenheimer Maintains Outperform on Gossamer Bio, Lowers Price Target to $3

Oppenheimer analyst Andreas Argyrides maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1
benzinga.com
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1

Health care sector has oversold stocks, RSI momentum indicator can help traders predict short term p

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

These Analysts Slash Their Forecasts On Gossamer Bio
benzinga.com
These Analysts Slash Their Forecasts On Gossamer Bio

benzinga.com
Wedbush Downgrades Gossamer Bio to Neutral, Lowers Price Target to $1

Wedbush analyst Laura Chico downgrades Gossamer Bio (NASDAQ:GOSS) from Outperform to Neutral and

benzinga.com
Barclays Downgrades Gossamer Bio to Underweight, Lowers Price Target to $0.3

Barclays analyst Eliana Merle downgrades Gossamer Bio (NASDAQ:GOSS) from Overweight to Underweigh

This Novo Nordisk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
benzinga.com
This Novo Nordisk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

benzinga.com
Leerink Partners Downgrades Gossamer Bio to Market Perform, Lowers Price Target to $1

Leerink Partners analyst Joseph Schwartz downgrades Gossamer Bio (NASDAQ:GOSS) from Outperform to

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Dow Tumbles Over 700 Points; Dominion Energy Posts Upbeat Earnings
benzinga.com
Dow Tumbles Over 700 Points; Dominion Energy Posts Upbeat Earnings

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

Gossamer Bio Plans FDA Talks After Narrow Miss In Key Pivotal Study, Stock Sinks
benzinga.com
Gossamer Bio Plans FDA Talks After Narrow Miss In Key Pivotal Study, Stock Sinks

Gossamer Bio shares plunge after Phase 3 pulmonary arterial hypertension data miss key mark, despite

US Stocks Mixed; Domino's Pizza Shares Gain After Q4 Earnings
benzinga.com
US Stocks Mixed; Domino's Pizza Shares Gain After Q4 Earnings

benzinga.com
Gossamer Bio Announces Results For PROSERA Phase 3 Study Of Seralutinib In Patients With PAH

- Seralutinib demonstrated a placebo-adjusted improvement in Six-Minute Walk Distance (6MWD) of +13.

benzinga.com
Barclays Initiates Coverage On Gossamer Bio with Overweight Rating, Announces Price Target of $9

Barclays analyst Eliana Merle initiates coverage on Gossamer Bio (NASDAQ:GOSS) with a Overweight

benzinga.com
HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a

10 Health Care Stocks Whale Activity In Today's Session
benzinga.com
10 Health Care Stocks Whale Activity In Today's Session

Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com
Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session

benzinga.com
Earnings Scheduled For May 15, 2025

benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga.com
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Frida

benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the comp

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 369 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 647 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 386 stocks made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  Friday's session saw 169 companies set new 52-week lows.

benzinga.com
Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday'

Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched larg

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 91 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  Thursday's session saw 337 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 497 companies set new 52-week lows.

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  OnFriday, 143 stocks hit new 52-week lows.

benzinga.com
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the co